One hundred years ago: The war against quackery in Germany

doi:10.1136/bmj.326.7385.365/a

BMJ 2003;326:365 ( 15 February )

Filler

One hundred years ago

The war against quackery in Germany

The first 150 words of the full text of this article appear below.

A German Society for the Repression of Quackery has just been founded at Berlin. The first public meeting was held on March8th, in the large Hall of the Rathhaus. Among the members of theSociety are a large number of laymen as well as medical practitioners.The object of the Society is to enlighten the public mind as tothe harm done by quackery to the public health, and as to theproper care of the sick. In furtherance of these objects, a regularpropaganda is to be instituted. Public meetings will be held andaddresses delivered; leaflets will be distributed and other meansof educating the man in the street will be adopted. The Societyalso proposes to take part in the meetings of quacks, in orderto confute their arguments and expose their misstatements. A weeklyjournal is to be founded, in which all the misdeeds of . . . [Full text of this article]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

StumbleUpon Add to Technorati

Technorati What's this?

Relevant Article

In praise of dissent
BMJ 2003 326: 0. [Full Text] [PDF]

This article has been cited by other articles:

Harrison, L. H. (2008). A Multivalent Conjugate Vaccine for Prevention of Meningococcal Disease in Infants. JAMA 299: 217-219 [Full text]
Harrison, L. H. (2006). Prospects for Vaccine Prevention of Meningococcal Infection. Clin. Microbiol. Rev. 19: 142-164 [Abstract] [Full text]
Trotter, C. L., Edmunds, W. J. (2006). Reassessing the Cost-Effectiveness of Meningococcal Serogroup C Conjugate (MCC) Vaccines Using a Transmission Dynamic Model. Med Decis Making 26: 38-47 [Abstract]
Keyserling, H., Papa, T., Koranyi, K., Ryall, R., Bassily, E., Bybel, M. J., Sullivan, K., Gilmet, G., Reinhardt, A. (2005). Safety, Immunogenicity, and Immune Memory of a Novel Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MCV-4) in Healthy Adolescents. Arch Pediatr Adolesc Med 159: 907-913 [Abstract] [Full text]
Diggle, M. A., Clarke, S. C. (2005). Increased Genetic Diversity of Neisseria meningitidis Isolates after the Introduction of Meningococcal Serogroup C Polysaccharide Conjugate Vaccines. J. Clin. Microbiol. 43: 4649-4653 [Abstract] [Full text]
Committee on Infectious Diseases, (2005). Prevention and Control of Meningococcal Disease: Recommendations for Use of Meningococcal Vaccines in Pediatric Patients. Pediatrics 116: 496-505 [Abstract] [Full text]
Pichichero, M. E. (2005). Meningococcal Conjugate Vaccine in Adolescents and Children. CLIN PEDIATR 44: 479-489 [Abstract]
Korioth, T. (2005). AAP issues guidance on use of meningococcal vaccines. AAP News 26: 1-17 [Full text]
Trotter, C. L., Gay, N. J., Edmunds, W. J. (2005). Dynamic Models of Meningococcal Carriage, Disease, and the Impact of Serogroup C Conjugate Vaccination. Am J Epidemiol 162: 89-100 [Abstract] [Full text]
Finn, A, Heath, P (2005). Conjugate vaccines. Arch. Dis. Child. 90: 667-669 [Full text]
Shepard, C. W., Ortega-Sanchez, I. R., Scott, R. D. II, Rosenstein, N. E., and the ABCs Team, (2005). Cost-Effectiveness of Conjugate Meningococcal Vaccination Strategies in the United States. Pediatrics 115: 1220-1232 [Abstract] [Full text]
Haase, M. R. (2004). Acute Bacterial Meningitis in Children. Journal of Pharmacy Practice 17: 392-406 [Abstract]
Jordens, J. Z., Williams, J. N., Jones, G. R., Christodoulides, M., Heckels, J. E. (2004). Development of Immunity to Serogroup B Meningococci during Carriage of Neisseria meningitidis in a Cohort of University Students. Infect. Immun. 72: 6503-6510 [Abstract] [Full text]
McVernon, J., Trotter, C. L, Slack, M. P E, Ramsay, M. E (2004). Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study. BMJ 329: 655-658 [Abstract] [Full text]
Joseph, H., Balmer, P., Bybel, M., Papa, T., Ryall, R., Borrow, R. (2004). Assignment of Neisseria meningitidis Serogroups A, C, W135, and Y Anticapsular Total Immunoglobulin G (IgG), IgG1, and IgG2 Concentrations to Reference Sera. CVI 11: 1-5 [Abstract] [Full text]
Balmer, P., Falconer, M., McDonald, P., Andrews, N., Fuller, E., Riley, C., Kaczmarski, E., Borrow, R. (2004). Immune Response to Meningococcal Serogroup C Conjugate Vaccine in Asplenic Individuals. Infect. Immun. 72: 332-337 [Abstract] [Full text]